Blood test to transform the way cancer is monitored and treated
Scientists have described a new type of test that can detect genetic mutations in minute amounts of DNA...
List view / Grid view
Scientists have described a new type of test that can detect genetic mutations in minute amounts of DNA...
A report published has identified the prospects of immunotherapy treatments...
A scientific collaboration has developed vascularised 3-D bioprinted liver tissue constructs, providing more precise drug toxicity testing...
US researchers have conjugated RNA to a molecule of folate, the folate receptor is overexpressed on cancer cells but very low on normal cells, which is why they can target a tumour and avoid healthy cells...
A novel chemical dubbed "T-REX," along with a patent-pending targeting molecule have uncovered interesting facets of several well-known cancer-cell mutations that, if present in a patient, could inform treatment options and potentially produce more favourable outcomes...
The move will help funded research progress toward the development of new therapeutics
Phase 2 trial to explore targeted therapies for children with solid tumours that harbour specific genetic mutations which have progressed during or after standard therapy...
Researchers have developed a new tools to increase immune response against cancer and infections...
The study demonstrates that tissue-resident and circulating memory T cells cooperate in anti-tumour immunity...
A team of researchers has patented a mobile device that can monitor cancer quickly, cheaply, effectively and noninvasively...
Cancer research at the University of Warwick has received a boost thanks to the former Lord Mayor of Coventry Cllr Lindsley Harvard.
A study led has found that the model for the spread of carcinoma - from the primary tumour, to nearby lymph nodes, to other organs - may not apply in all cases.
The DFG has agreed to fund the Mainz-based Collaborative Research Center involved in the development of nanomaterials for cancer immunotherapy...
A team of researchers has discovered the role of the protein ZBTB48 in regulating both telomeres and mitochondria, key players involved in cellular ageing.
A method to more accurately test anti-cancer drugs has now been developed at the Sahlgrenska Academy, University of Gothenburg.